Overview: Typhus Fever IgG IgM Antibody Panel TestIntroduction: The Typhus Fever IgG IgM Antibody Panel Test detects Rickettsia antibodies to diagnose typhus fever, causing fever or rash. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected typhus fever.
Other Names: Typhus Antibody Panel, Rickettsia IgG IgM Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Typhus antibody testing began in the 1940s with rickettsial research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Rickettsia IgG and IgM antibodies to diagnose typhus fever, guides treatment, and evaluates patients with fever or rash.
Test Parameters: 1. Rickettsia IgG & IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, rash, or typhus exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, rash, or history of typhus exposure, especially in endemic areas. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, typhus fever implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or immunofluorescence to detect Rickettsia IgG and IgM antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for typhus diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Cross-reactivity with other rickettsial infections may reduce specificity.
Clinical Significance: Positive IgM indicates acute typhus, guiding antibiotic therapy like doxycycline. Positive IgG suggests past exposure. Negative results may require PCR.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Rickettsia PCR, Weil-Felix test, or clinical evaluation to confirm typhus fever diagnosis.
Test Limitations: Non-specific for acute versus past infection; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Infectious Disease Guidelines, 2023; Clinical Infectious Diseases, Walker DH, 2022.
